Draupnir Bio ApS
38546880ActivePioneering oral small molecule degraders for extracellular disease proteins.
Oversikt
- 8
- Ansatte
- Ukjent
- Omsetning
- 2017
- Grunnlagt
Nøkkelbeslutningstakere
Eva-Lotta Allan
Chair of the Board
Peter Seeberger
Co-Founder
Stefan Luzi
Board Member
Ivan Burkov
Board Member
+7 flere kontakter i Funnelfeedr
Beskrivelse
Draupnir Bio is a Danish biotechnology company that specializes in the field of targeted protein degradation. The organization was founded as a spin-out from Aarhus University and the Max-Planck Society to pioneer new therapeutic approaches. They focus on developing oral, small molecule degraders th...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- APS
- MVA-nummer
- DK38546880
Beslutningstakere
11 kontakter i FunnelfeedrEva-Lotta Allan
Chair of the Board
Peter Seeberger
Co-Founder
Stefan Luzi
Board Member
Ivan Burkov
Board Member
Camilla Gustafsen
Co-Founder and VP Biology
Andrew Hotchkiss
Chief Executive Officer
Emmanuelle Coutanceau
Board Member
Rob Scott
Independent Director
Simon Glerup
Co-Founder and Chief Scientific Officer
Casper Tind Hansen
Chief Business Officer
Peder Søndergaard Madsen
Co-Founder
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrOrbis Medicines ApS
26 ansatteOrbis Medicines develops oral macrocycle drugs using an AI-powered platform.
Skape Bio ApS
10 ansatteAI-driven biotechnology company designing novel miniproteins for GPCR drug discovery.
SACRA Therapeutics AB
0 ansatteSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Abarceo Pharma AB
5–9 ansatteDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
Kvasir Technologies ApS
20 ansatteConverting plant biomass waste into sustainable, CO2-neutral marine biofuels.
Spørsmål om Draupnir Bio ApS
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo